https://biotechmorning.com/news/roche-pathai-acquisition-billion-dollar-ai-pathology Biotech Morning en 2026-05-08T14:14:05.678Z Roche Just Paid $1 Billion for a Pathologist That Never Sleeps https://biotechmorning.com/news/blackstone-250m-anagram-cystic-fibrosis Biotech Morning en 2026-05-08T14:13:24.639Z The $250M Bet That CF Patients Shouldn't Swallow So Many Pills a Day https://biotechmorning.com/news/ascendis-kills-promising-il2-cancer-drug Biotech Morning en 2026-05-08T14:12:41.230Z Ascendis Had a Promising Cancer Drug. They Killed It Anyway. https://biotechmorning.com/news/odyssey-therapeutics-ipo-comeback Biotech Morning en 2026-05-08T14:12:00.760Z The Biotech IPO That Came Back From the Dead https://biotechmorning.com/news/angelini-acquires-catalyst-pharmaceuticals Biotech Morning en 2026-05-08T14:11:23.482Z Italy's Biggest Bet on American Biotech Just Landed https://biotechmorning.com/news/five-biotech-buyouts-one-week-ma-frenzy Biotech Morning en 2026-05-08T14:10:39.041Z Biotech Buyouts Pile Up: What's Driving the M&A Frenzy? https://biotechmorning.com/news/ipsen-albireo-liver-disease-candidates-terminated Biotech Morning en 2026-05-07T14:14:17.391Z Ipsen Spent $952M on a Company. Two of Its Drugs Just Hit the Trash. https://biotechmorning.com/news/sanofi-fda-voucher-program-withdrawal Biotech Morning en 2026-05-07T14:13:38.958Z Sanofi Just Broke Up With the FDA's Fastest Review Program https://biotechmorning.com/news/one-bad-day-killed-this-70m-biotech Biotech Morning en 2026-05-07T14:13:02.965Z One Bad Day Killed This $70M Biotech https://biotechmorning.com/news/avalo-phase-2-hs-results-abbvie-competition Biotech Morning en 2026-05-07T14:12:24.068Z The Tiny Biotech That Just Embarrassed AbbVie's Dermatology Team https://biotechmorning.com/news/fda-blinked-rare-cancer-drug-reversal Biotech Morning en 2026-05-07T14:11:39.587Z The FDA Just Blinked on a Rare Cancer Drug It Already Killed https://biotechmorning.com/news/ucb-acquires-candid-therapeutics-2-billion-2 Biotech Morning en 2026-05-07T14:11:00.411Z UCB Just Dropped $2.2 Billion on a Company That Didn't Exist Two Years Ago https://biotechmorning.com/news/fda-real-time-clinical-trial-data-pilot Biotech Morning en 2026-05-07T14:10:17.199Z The FDA Just Killed the 60-Year-Old Way We Run Clinical Trials https://biotechmorning.com/news/primate-act-ban-monkey-imports-drug-development Biotech Morning en 2026-05-07T14:09:42.474Z Congress Wants to Ban Monkey Imports. Drug Developers Are Nervous. https://biotechmorning.com/news/cytospire-83m-gamma-delta-t-cell-engager Biotech Morning en 2026-05-07T14:09:01.492Z The $83M Bet on Your Body's Forgotten Immune Cells